Inhibition of NF-κB Signaling by Quinacrine Is Cytotoxic to Human Colon Carcinoma Cell Lines and Is Synergistic in Combination with Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) or Oxaliplatin-Reference-Cited by-同舟云学术

Inhibition of NF-κB Signaling by Quinacrine Is Cytotoxic to Human Colon Carcinoma Cell Lines and Is Synergistic in Combination with Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) or Oxaliplatin

Published:2010-06 Issue:25 Volume:285 Page:19162-19172
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Jani Tanvi S.,DeVecchio Jennifer,Mazumdar Tapati,Agyeman Akwasi,Houghton Janet A.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference108 articles.

1. Colorectal Cancer Facts and Figures 2008–2010,2008

2. Cancer Facts and Figures 2009,2009

3. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation

4. Oxaliplatin

5. Colorectal cancer: Integrating oxaliplatin

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AI identifies potent inducers of breast cancer stem cell differentiation based on adversarial learning from gene expression data;Briefings in Bioinformatics;2024-03-27

2. Repurposing antiparasitic drugs for the treatment of other diseases;Advances in Antiparasitic Therapies and Drug Delivery;2024

3. Critical signaling pathways governing colitis-associated colorectal cancer: Signaling, therapeutic implications, and challenges;Digestive and Liver Disease;2023-02

4. Quinacrine enhances the efficacy of cisplatin by increasing apoptosis and modulating cancer survival proteins in a colorectal cancer cell line;Journal of Cancer Research and Therapeutics;2023

5. ROS, Redox Regulation, and Anticancer Therapy;Redox Regulation and Therapeutic Approaches in Cancer;2023